Emanuela Romano

12PUBLICATIONS
86CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)AllergyTumour immunologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jun 25, 2026
Neoadjuvant stereotactic body radiation therapy with durvalumab and oleclumab in ER+HER2- breast cancer: a randomized phase 2 trial.

|Jun 11, 2025
Phase I and II Clinical Studies of the STING Agonist Ulevostinag with and without Pembrolizumab in Participants with Advanced or Metastatic Solid Tumors or Lymphomas.

Kevin J Harrington, Stephane Champiat, Joshua D Brody

|Sep 23, 2024
At the Interface of Tumor-Associated Macrophages and Fibroblasts: Immune-Suppressive Networks and Emerging Exploitable Targets.

Eleonora Timperi, Hugo Croizer, Darya Khantakova

|Sep 03, 2024
Use of Pretreatment Perfusion MRI-based Intratumoral Heterogeneity to Predict Pathologic Response of Triple-Negative Breast Cancer to Neoadjuvant Chemoimmunotherapy.

Toulsie Ramtohul, Victoire Lepagney, Claire Bonneau

|Apr 01, 2024
Deciphering the spatial landscape and plasticity of immunosuppressive fibroblasts in breast cancer.

Hugo Croizer, Rana Mhaidly, Yann Kieffer

|Nov 03, 2023
Paclitaxel plus carboplatin and durvalumab with or without oleclumab for women with previously untreated locally advanced or metastatic triple-negative breast cancer: the randomized SYNERGY phase I/II trial.

Laurence Buisseret, Delphine Loirat, Philippe Aftimos

Pageof 2

Frequent Collaborators

4 joint publications

Laurence Buisseret

4 joint publications

Anne Vincent-Salomon

3 joint publications

Christos Sotiriou

3 joint publications

Martine Piccart-Gebhart